Kokoromiru Inc. (Headquarters: Shinjuku-ku, Tokyo; CEO: Daiki Hayashi), a company developing medical devices and providing health analysis services, conducted a questionnaire survey targeting participants of the 'Home Heart Dock Pro' program in Yamanashi Prefecture's '9th Phase TRY! YAMANASHI! Demonstration Experiment Support Project.' The survey focused on participants' daily health awareness and medical visit behaviors, including employees from local companies.
The results highlighted that nearly half of respondents hesitate to seek medical care despite feeling unwell, and 98% of participants in this regional city had no prior experience with telemedicine, revealing significant healthcare access challenges. On the other hand, over 70% of participants experienced 'behavioral change'—such as improved awareness or actual medical visits—after using the at-home ECG analysis service.
Survey Results on Business Professionals' Barriers to Medical Visits
① Background of Business Professionals' Reluctance to Seek Medical Care
When asked, 'Do you sometimes avoid visiting medical institutions despite health concerns?' a combined 45% answered 'frequently' or 'occasionally.' The most common reason (multiple answers allowed) was 'too busy, no time available' (38 responses), followed by 'thought it might be fine to just monitor the condition' (24 responses), indicating a strong tendency to underestimate their symptoms.
Approximately 30% (28%) do not have a regular primary care physician they can consult routinely.
② Paradigm Shift from 98% 'No Telemedicine Experience'
Before participating, 98% of respondents answered they had 'no experience with or little knowledge of' telemedicine, highlighting the low penetration of remote healthcare in regional cities. However, after experiencing the end-to-end model of 'Home Heart Dock Pro test → online consultation → referral to local medical institutions (if needed),' 87% responded that 'it was easier to understand the referral details and locations from online consultations,' enabling a smooth transition to actual medical visits.
③ Real Behavioral and Psychological Changes After Testing
After reviewing their test reports, 50% reported 'making lifestyle improvements,' and an additional 19% answered they 'visited or consulted a medical institution for the first time due to this test.' In open-ended responses, participants noted, 'I knew I was stressed, but seeing the poor sleep quality clearly made me more proactive about improving my daily life,' demonstrating that data visualization can act as a trigger for behavioral change.
④ Requests from Companies and Management for Social Implementation
Regarding the expansion of this system within the prefecture, 82% combined answered 'strongly hope it spreads' or 'somewhat hope it spreads.' However, open-ended responses also included practical feedback from a management perspective:
'The initiative is excellent, but from a managerial standpoint, the cost is a concern. We hope you explore collaboration with the Ministry of Health, Labour and Welfare to link this to government subsidies or bonus-point systems.'
'If there is some form of subsidy, as in this case, it becomes easier for companies to participate.'
In response to this feedback, our company will not only provide products but also focus on creating an environment conducive to corporate adoption—such as leveraging municipal subsidy programs and building schemes that qualify as bonus points in the Health Management Excellent Company Certification.
Summary of Survey Results
① Over 40% avoid medical visits despite health concerns; the biggest barriers are 'lack of time (38 responses)' and 'underestimation of symptoms (24 responses).'
② Current state of digital healthcare in regional cities: 98% are 'inexperienced with telemedicine.'
③ Evidence of behavioral change: Many participants made 'lifestyle improvements' or 'visited/consulted a medical institution for the first time' due to the test.
④ Honest feedback from managers and users: Expectations for 'linking to government subsidies and health management bonus-point systems.'
Survey Overview
Target: Participants of the experience seminar for Yamanashi Prefecture's '9th Phase TRY! YAMANASHI! Demonstration Experiment Support Project'
Number of Respondents: 17
Survey Period: Mid-December 2025 to end of February 2026 (during the demonstration experiment)
Survey Method: Questionnaire survey conducted after the experiment
About Home Heart Dock Pro
'Home Heart Dock Pro' is a long-term ECG testing service that can be performed at home.
A small ECG monitor is attached to the chest to collect ECG data for over nine hours. Clinical laboratory technicians analyze the results and provide a detailed report. Long-term ECG monitoring enables the detection of hidden cardiovascular risks that standard health checkups or human dock exams—typically lasting only about 15 seconds—often miss.
Additionally, it simultaneously detects sleep apnea syndrome (SAS), sleep quality, and signs of stress.
An online clinic is also available; if desired, users can receive medical consultations from home and obtain referral letters to university hospitals.
Despite using medical devices, Home Heart Dock Pro allows testing at home, enabling users to access medical-grade examinations without the hassle of hospital visits. It is highly praised by middle-aged and elderly individuals with busy schedules, as well as those in remote areas with limited access to hospitals.
Home Heart Dock Pro (Sales Page) https://homeheart.health/products/homeheart-pro01
Kokoromiru Inc.
— Eliminating Sudden Death Worldwide with the Mission of 'A Society Without Regret from Illness' —
We operate various businesses, including 'Home Heart Dock®,' which enables easy, hospital-equivalent comprehensive ECG checks from home. By acquiring long-term data, we visualize cardiovascular risks often missed in conventional health screenings and human dock exams, aiming to save 100 million lives worldwide that were previously lost to sudden death.
Additionally, through the data collected, we aim to help many people visualize their own and their families' health conditions, thereby improving healthspan and quality of life (QOL).
CEO: Daiki Hayashi Headquarters: 2F, Kanno Building, 6-2-16 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023 Established: November 2021 Business: Healthcare and clinical research Services Provided: <For Individuals> 'Home Heart Dock®' — visualizing arrhythmia, sleep apnea syndrome (SAS), sleep quality, and stress signs using ECG <For Medical Institutions> Disposable Holter ECG monitor 'eclat' <For Medical Institutions> Animal medical ECG monitoring and Holter testing
Product Name: eclat (Éclat) Generic Name: Long-term ECG Data Recorder Medical Device Classification: Regulated Medical Device (Class II), Specific Maintenance Management Medical Device
Main Licenses, Approvals, and Certifications: Class II Medical Device Manufacturing and Sales License (Permit No.: 13B2X10584) Medical Device Manufacturing License (Registration No.: 13BZ201797) Highly Regulated Medical Device Sales and Rental License (Permit No.: 5 Shinbo Eiyaku No. 162) ISO 13485:2016 Certified
Website: https://kokoromil.com/
d98284-140-53913cd4ed85ebdf0cce9910eb13a816.pdf
FACT BOX
- Source: PR TIMES
- Category: Survey
- Products / services: eclat